HALLE MAGEE: Open Payments
NPI 1366126336 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 16 payments from 11 companies in 2025. Trend: 2023 $34 · 2024 $1,183 · 2025 $439
Food & beverage: $361Education: $78
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 4 | $87 |
| SEAGEN INC. | 1 | $78 |
| PFIZER INC. | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| TAIHO ONCOLOGY, INC. | 1 | $26 |
| Lilly USA, LLC | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Braintree Laboratories, Inc. | 1 | $24 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $23 |
Products named: PROVENGE, KEYTRUDA, XTANDI, JEMPERLI, PADCEV, LONSURF, VERZENIO, Nubeqa.
Industry payments across TX — which companies pay providers there.
